Evidence map›Paper›PMID 29260243›Full record

ReviewDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2018

[Perioperative handling of antidiabetic drugs].

J Wagner, V Luber, J F Lock, U A Dietz, S Lichthardt, N Matthes, K Krajinovic, C-T Germer, S Knop, A Wiegering

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

J WagnerKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
V LuberKlinik für Innere Medizin II, Universitätsklinikum Würzburg, Würzburg, Deutschland.
J F LockKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
U A DietzKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
S LichthardtKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
N MatthesKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
K KrajinovicKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
C-T GermerKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.
S KnopKlinik für Innere Medizin II, Universitätsklinikum Würzburg, Würzburg, Deutschland.
A WiegeringKlinik für Allgemein‑, Viszeral‑, Gefäß- und Kinderchirurgie, Universitätsklinikum Würzburg, Julius-Maximilians-Universität, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland. wiegering_a@ukw.de.
Universitätsklinikum Würzburg · DEComprehensive Cancer Center Mainfranken · DEUniversitäts-Kinderklinik Würzburg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is the most frequent metabolic disorder in the western world with a prevalence of 3% in adults under 65 years of age and 14.3% in adults over 65 years of age. Due to the increasing age of our population, the number of patients taking oral antidiabetic drugs has increased. Thus, operating physicians must make a risk-adapted decision whether the medication can be continued perioperatively or if certain drugs must be paused, and if so, with what risks. Operative interventions can lead to a number of metabolic shifts, which change the normal glucose metabolism. Hyperglycemia in the perioperative period is a risk factor for postoperative sepsis, dysfunction of the endothelium, cerebral ischemia and poor wound healing. Due to perioperative fasting oral antidiabetic medication can lead to severe hypoglycemia if taken during this period. This leads to an increased morbidity and mortality in the perioperative period and extends the duration of stay in the intensive care unit (ICU) as well as the overall hospital stay. Oral antidiabetic medication should be paused on the day of the operation and restarted in line with the gradual postoperative return to solid food. Especially metformin, the most commonly used medication in the treatment of type 2 diabetes, should be paused perioperatively due to the severe side effect of lactate acidosis.

Indexed as

Diabetes Mellitus, Type 2HypoglycemiaHypoglycemic AgentsPerioperative PeriodAdultAgedHumansPrevalenceRisk FactorsHypoglycemic AgentsChronic medicationHypoglycemiaOral antidiabetic drugsPreoperative pauseRisk stratification

Identifiers

PMID29260243
OpenAlexW2778782722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.